Decitabine in myelodysplastic syndromes: viewpoints.
Garcia-Manero
Guillermo
G
Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
Saba
Hussain I
HI
D000964:Antimetabolites, Antineoplastic / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use; D019540:Area Under Curve; D001374:Azacitidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D000077209:Decitabine; D006801:Humans; D015394:Molecular Structure; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D000077209:Decitabine; D001374:Azacitidine